{"name":"Bayhill Therapeutics","slug":"bayhill-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BHT-3009-01","genericName":"BHT-3009-01","slug":"bht-3009-01","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"BHT-3009-01","genericName":"BHT-3009-01","slug":"bht-3009-01","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE92OG1QZ2x6cmtkQ2luOWE4UkpmYjhESm16QVcwUURJbmNkRkpaeXZRaU01MXVPQzBSWUtGZXNLVjZ1dnltN3VJQk96QnVjWmxnd24wVzBzVnJjc2JwQzJfLUNwMWNrY092M1JFSTZmWmVrSW9n?oc=5","date":"2022-08-19","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—PerkinElmer's Mock dons CFO mantle at Moderna - Fierce Biotech","headline":"Chutes & Ladders—PerkinElmer's Mock dons CFO mantle at Moderna","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBXbTNnWFp4SVFERFRCWGJ5RzF1YXQ5VGV0S000al93blc4VWxSZzFMTzdweXgxVXNKbGNGZXdEZTVuQklpWmg3ay1EbG5nLVF2ZW41Xw?oc=5","date":"2018-01-03","type":"pipeline","source":"Nature","summary":"The inverse of immunity - Nature","headline":"The inverse of immunity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOMmlHSmZjYlNJaUlpUnloVHRlVE9VeF95VlBGLW4yT2xVLTEyWWtzNnczbFVSSUJQTjBGamttZnBpUDJRaGllMUVNVWp2blNTV09sVlBUajJXcUhZbnVFaGJ0WFM3Y2hJMHdROUhmamVKMEJFdy04NWJLNG5IaFpMTzhxWW1EY2xsQlY2QUdxTVBDc0tPeDc2V0NHYVY2RXozdl9ZMmg1WmY0SmZKY1Zv?oc=5","date":"2014-08-21","type":"pipeline","source":"BioSpace","summary":"Galena Biopharma CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named - BioSpace","headline":"Galena Biopharma CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1TSTV2ajBiUzJCeENzN2hvel82ckExRzRENGhwSy1sOUNIVlZnSnFqN25IRkxaUlZoN2p2MC1rQi1oZXRONnkxUW02Z1MwQW5USzQ0cld2TkV0dWRURzhXdnVZbHVjRVlxNDhoOEg5eENuMjNTeDNZZThaNDVoZ1k?oc=5","date":"2009-01-05","type":"pipeline","source":"Contract Pharma","summary":"Xoma, Ltd. - Contract Pharma","headline":"Xoma, Ltd.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNUzh1UmRMbEptclVYSkNfWHpNXzBCb1ZTSWxGUmI1N1pIaU8xTF90a2pZQko4cFNYa1dBTElBa1FvQU5wMll6YnZpQ3U1eU1lTm1lS19jZkRUMGxrRmNEMEh6Ty1VWHBfaFhpM1FFVHhrUkwzNC1McS1KTVZmQ3EyLUxBcUtFak1idlJ5eW4yREZMQURrSy1lSWxpdw?oc=5","date":"2008-12-15","type":"pipeline","source":"hamilton.edu","summary":"FibroGen, Inc. Names Dr. Frank Valone '70 Chief Medical Officer - hamilton.edu","headline":"FibroGen, Inc. Names Dr. Frank Valone '70 Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}